Company news
Victrex Plc (LSE:VCT) news
Victrex Plc news releases on 6ix. Latest, Oct 5, 2026: Holding(s) in Company
Press releases & updates
Holding(s) in Company
October 5, 2026
Total Voting Rights
September 30, 2026
Capital Markets Event
September 24, 2026
Pre-Close Trading Update
September 9, 2026
From Material Innovation to a More Sustainable Future: Victrex Recognised by the FTSE Green Economy Mark
July 27, 2026
Block Listing Application
July 2, 2026
Maven Renovar VCT : Annual Report 2026 ( VCT PLC Annual Report 2026eb)
May 21, 2026
Victrex : Interim results 2026
May 13, 2026
Half-year Financial Report
May 11, 2026
Global Polyaryletherketone Market Highlights Germany’s Dominance, Led by Victrex Plc, Evonik Industries, and Arkema SA
April 15, 2026
Holding(s) in Company
March 24, 2026
Total Voting Rights
February 27, 2026
SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms
February 18, 2026
Director/PDMR Shareholding
February 17, 2026
Directorate change
February 10, 2026
Result of AGM
February 6, 2026
Q1 Trading Update
February 6, 2026
Victrex : Resolutions passed as Special Business at AGM
February 5, 2026
Additional Listing
January 20, 2026
Annual Financial Report
December 22, 2025
Director/PDMR Shareholding - Replacement
December 18, 2025
Share purchase by incoming Director (incoming CEO)
December 5, 2025
Financial Calendar Update
December 4, 2025
Preliminary Results
December 2, 2025
Block listing Interim Review
December 1, 2025
CEO Succession update
October 21, 2025
HSBC HOLDINGS PLC ANNOUNCES RESULTS OF ITS TENDER OFFERS FOR FOUR SERIES OF NOTES
September 9, 2025
PEEK Company Benchmark Report 2025 | Victrex, Evonik, and Syensqo Strengthen Leadership in PEEK Through Innovation, Global Expansion, and Strategic Partnerships
August 25, 2025
Q3 Trading Update
July 8, 2025
Directorate change: CEO succession
July 8, 2025
Director Declaration
June 30, 2025
Victrex : First PEEK-OPTIMA™ Cases Performed in US IDE Study with Maxx Orthopedics’ Freedom® Total Knee System
June 19, 2025
Appointment of Joint Corporate Broker
June 18, 2025
Victrex : Interim results 2025
May 21, 2025
Victrex plc – Interim Results 2025
May 12, 2025
‘Magma’ advances via TechnipFMC award
May 7, 2025
AGM and Trading Update
February 7, 2025
Victrex plc - Preliminary Results 2024
December 3, 2024
Victrex : Statement with China Distributors Details
November 30, 2024
Victrex : Nvision Biomedical Technologies™ Secures FDA Clearance for First 3D Printed Porous PEEK Interbody System made with Invibio PEEK OPTIMA™
September 25, 2024
US FDA approval: Total Knee Study
September 17, 2024
Q3 Interim Management Statement
July 4, 2024
Victrex : Interim Results 2024
June 6, 2024
SBTI approval of carbon reduction targets
May 23, 2024
Victrex plc - Interim Results 2024
May 13, 2024
Directorate Change
March 15, 2024
AGM & Q1 Interim Management Statement
February 9, 2024
Annual Report & Accounts
January 9, 2024
Victrex plc - Preliminary Results 2023
December 5, 2023
Victrex plc - Q3 Interim Management Statement
July 6, 2023